NDAORALCAPSULE, EXTENDED RELEASE
Approved
Dec 2004
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
20
Data completeness
6/8 — Strong
EQUETRO (carbamazepine) by Bausch Health is cytochrome p450 3a4 inducers [moa]. Approved for epilepsy, bipolar disorder. First approved in 2004.
Drug data last refreshed Yesterday · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
EQUETRO is an extended-release oral capsule formulation of carbamazepine, a cytochrome P450 3A4 inducer used to treat epilepsy, bipolar disorder, neuropathic pain, and other neuropsychiatric conditions. It stabilizes mood and reduces seizure activity through enzyme induction and membrane stabilization mechanisms. The drug serves multiple therapeutic areas including neurology and psychiatry.
$0.001BPart D
LOE ApproachingDeclining
As an LOE-approaching product with only $1M in Part D spending and 2,882 claims (2023), EQUETRO faces significant competitive pressure and likely operates with a smaller, more focused brand team.
Mechanism of Action
Cytochrome P450 3A4 Inducers
Pharmacologic Class:
Mood Stabilizer
Indications (2)
Clinical Trials (20)
Drug-drug Interaction Trial of AP31969 and Carbamazepine or Itraconazole
Started Apr 2026
28 enrolled
Healthy Participants
A Trial to Examine the Interaction of Repinatrabit With Ethinyl Estradiol/Norethindrone, Metformin,Carbamazepine, Rosuvastatin, and Methotrexate When Administered Together
Started Mar 2026
48 enrolled
Healthy Volunteers
A Study to Learn How Fluconazole, Carbamazepine and Itraconazole Affect How the Body Processes ASP3082 in Healthy Adults
Started Feb 2026
54 enrolled
Healthy Volunteer
To Assess the Enzyme Inducing Effects of Carbamazepine on the PK of Mirdametinib in Healthy Participants
Started Dec 2025
36 enrolled
HealthyVolunteer
A Study to Learn if Multiple Doses of the Study Medicine Called Carbamazepine Changes How the Body Processes the Other Study Medicine PF-07248144
Started Sep 2025
12 enrolled
Healthy Adults
Worked on EQUETRO at Bausch Health? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.